Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17812511 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL42509 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1400502 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL579965 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL14522676 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1218314 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL9410611 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL1218319 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL2430831 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA | |
| SCHEMBL28058 | 1.00 | NAAA (0.58) | NAAARAD52NPSR1FAAHDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315576-B | Preparation method of bio-based degradable plasticizer | 山东万图高分子材料股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| EP-3810135-A1 | ENHANCEMENT OF DELIVERY OF LIPOPHILIC ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Poviva Corp. (US) | 2021-04-28 | — | — | EP | claimed |
| EP-3781163-A1 | COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF | Poviva Corp. (US) | 2021-02-24 | — | — | EP | claimed |
| US-20210045998-A1 | TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS | Poviva Corp. | 2021-02-18 | — | — | US | claimed |
| WO-2019202396-A1 | COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF | POVIVA TEA, LLC (US) | 2019-10-24 | — | — | WO | claimed |
| EP-2448433-A2 | OMEGA-3 FATTY ACID ENRICHED BEVERAGES | Solae, LLC (US) | 2012-05-09 | — | — | EP | claimed |
| EP-2448431-A2 | OMEGA-3 FATTY ACID ENRICHED BAKED FOODS AND BAR COMPOSITIONS | Solae, LLC (US) | 2012-05-09 | — | — | EP | claimed |
| US-20120107478-A1 | Omega-3 Fatty Acid Enriched Baked Foods and Bar Composition | SOLAE, LLC (US) | 2012-05-03 | — | — | US | claimed |
| US-20120100257-A1 | Omega-3 Fatty Acid Enriched Beverages | SOLAE, LLC (US) | 2012-04-26 | — | — | US | claimed |
| CN-102395343-A | Absorbent articles comprising wetness indicators | PROCTER & GAMBLE | 2012-03-28 | — | — | CN | claimed |
| WO-2011002802-A2 | OMEGA-3 FATTY ACID ENRICHED BAKED FOODS AND BAR COMPOSITIONS | SOLAE, LLC (US) | 2011-01-06 | — | — | WO | claimed |
| WO-2011002805-A2 | OMEGA-3 FATTY ACID ENRICHED BEVERAGES | SOLAE, LLC (US) | 2011-01-06 | — | — | WO | claimed |
| EP-1951847-A2 | BIODIESEL FUEL COMPOSITIONS HAVING INCREASED OXIDATIVE STABILITY | Novus International, Inc. (US) | 2008-08-06 | — | — | EP | claimed |
| US-20080019860-A1 | LIQUID MONOPHASIC LIPID-SOLUBLE ANTIOXIDANT COMPOSITIONS AND PROCESSES FOR MAKING THE COMPOSITIONS | NOVUS INTERNATIONAL INC. (US) | 2008-01-24 | — | — | US | claimed |
| WO-2008011272-A2 | LIQUID MONOPHASIC LIPID-SOLUBLE ANTIOXIDANT COMPOSITIONS AND PROCESSES FOR MAKING THE COMPOSITIONS | NOVUS INTERNATIONAL INC. (US) | 2008-01-24 | — | — | WO | claimed |
| WO-2007062304-A2 | BIODIESEL FUEL COMPOSITIONS HAVING INCREASED OXIDATIVE STABILITY | NOVUS INTERNATIONAL, INC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070113467-A1 | BIODIESEL FUEL COMPOSITIONS HAVING INCREASED OXIDATIVE STABILITY | NOVUS INTERNATIONAL INC. (US) | 2007-05-24 | — | — | US | claimed |
| US-20040180021-A1 | Composition comprising at least one film-forming polymer | L'OREAL S.A. (FR) | 2004-09-16 | — | — | US | claimed |
| EP-1428494-A1 | Mascara comprising filmbuilding polymer and fatty phase | L'OREAL (FR) | 2004-06-16 | — | — | EP | claimed |
| WO-2004041220-A2 | COMPOSITION CONTAINING A SEMI-CRYSTALLINE POLYMER AND A PASTY FATTY SUBSTANCE | L'OREAL (FR) | 2004-05-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045998-A1 | TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS | LIPA, MMP8, MMP1 | NAAA 1359/4885RAD52 3052/4885NPSR1 1437/4885 |
| US-20040180021-A1 | Composition comprising at least one film-forming polymer | KRT18, CUTA, DSG1 | NAAA 3307/4885RAD52 860/4885NPSR1 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.